Year | Volume (Price x Shares) | Change |
---|---|---|
2023 | $0.21 B | -58.23% |
2022 | $0.51 B | -20% |
2021 | $0.64 B | 402.3% |
2020 | $0.12 B | -31.62% |
2019 | $0.18 B | -56.08% |
2018 | $0.42 B | 535.89% |
2017 | $67.44 M | -64.21% |
2016 | $0.18 B | -29.02% |
2015 | $0.26 B | 2.16% |
2014 | $0.25 B | 138.9% |
2013 | $0.10 B |
Company | FTD volume (3months) | FTD volume (1 year) | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $66.53 M | $0.31 B | ๐บ๐ธ USA |
![]() Novartis NVS | $3.93 M | $0.10 B | ๐จ๐ญ Switzerland |
![]() Pfizer PFE | $0.23 B | $0.56 B | ๐บ๐ธ USA |
![]() Abbott Laboratories ABT | $25 M | $88.77 M | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $42.87 M | $0.29 B | ๐บ๐ธ USA |
![]() Amgen AMGN | $81.07 M | $0.51 B | ๐บ๐ธ USA |
![]() Sanofi SNY | $38.16 M | $0.11 B | ๐ซ๐ท France |
![]() Bristol-Myers Squibb BMY | $63.47 M | $0.22 B | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | $27.64 M | $72.38 M | ๐ฌ๐ง UK |
![]() Teva Pharmaceutical Industries TEVA | $3.71 M | $35.54 M | ๐ฎ๐ฑ Israel |